Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ethics and policy perspectives on personalized medicine in the post-genomic era.

The journal of biolaw & business - 1 Jan 2005

Landon Melissa R

Abstract excerpt

The completion of the human genome project and the accompanying biotechnological revolution hold great promise for the creation of pharmaceutical agents to combat not only previously incurable diseases, but also those for which therapeutics exist, yet they either cause severe adverse effects or exhibit no benefit in subsets of the population. In many instances variation in therapy response can be attributed to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Informed Consent
Share to Clinical Trials, Phase I as Topic
Share to Clinical Trials, Phase II as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials, Phase III as Topic

Share to Drug Industry

Share to Genetic Privacy

Share to Government Regulation

Share to United States Food and Drug Administration

Source

Identifiers

PMID: 16459425

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ethics and policy perspectives on personalized medicine in the post-genomic era.PMID 16459425Read ↗

Ethical and legal implications of pharmacogenomics.Semantic proximity Read ↗

Ethical, social and legal issues in pharmacogenomicsSemantic proximity Read ↗

Pharmacogenetics: ethical issues and policy options.Semantic proximity Read ↗

Ethical considerations in clinical pharmacogenomics researchSemantic proximity Read ↗

Genomic medicine: health care issues and the unresolved ethical and social dilemmas.Semantic proximity Read ↗

Pharmacogenetic Testing: A Tool for Personalized Drug Therapy OptimizationSemantic proximity Read ↗

Clinical and moral challenges of pharmacogenomics.Semantic proximity Read ↗

Knowledge and skills needs for health professions about pharmacogenomics testing field.Semantic proximity Read ↗

Privacy and Confidentiality of Genetic Information: What Rules for the New Science?Semantic proximity Read ↗

Applying an equity lens to pharmacogenetic research and translation to under-represented populations.Semantic proximity Read ↗

Translating Personalized Medicine Using New Genetic Technologies in Clinical Practice: The Ethical IssuesSemantic proximity Read ↗

Patient privacy in the genomic era.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.